François R Jornayvaz

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Insulin Resistance

Systematic Review

Cardiovascular Risk Factors

Top Venues

Science advances

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Gloria Ursino, Giulia Lucibello, Pryscila D S Teixeira, Anna Höfler, Christelle Veyrat-Durebex, Soline Odouard, Florian Visentin, Luca Galgano, Emmanuel Somm, Claudia R Vianna, Ariane Widmer, François R Jornayvaz, Andreas Boland, Giorgio Ramadori, Roberto Coppari
S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Science advances 10 (1) (2024)
Gloria Ursino, Giulia Lucibello, Pryscila D S Teixeira, Anna Höfler, Christelle Veyrat-Durebex, Soline Odouard, Florian Visentin, Luca Galgano, Emmanuel Somm, Claudia R Vianna, Ariane Widmer, François R Jornayvaz, Andreas Boland, Giorgio Ramadori, Roberto Coppari
S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Science advances 10 (1) (2024)
Gloria Ursino, Giulia Lucibello, Pryscila D S Teixeira, Anna Höfler, Christelle Veyrat-Durebex, Soline Odouard, Florian Visentin, Luca Galgano, Emmanuel Somm, Claudia R Vianna, Ariane Widmer, François R Jornayvaz, Andreas Boland, Giorgio Ramadori, Roberto Coppari
S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Science advances 10 (1) (2024)
Gloria Ursino, Giulia Lucibello, Pryscila D S Teixeira, Anna Höfler, Christelle Veyrat-Durebex, Soline Odouard, Florian Visentin, Luca Galgano, Emmanuel Somm, Claudia R Vianna, Ariane Widmer, François R Jornayvaz, Andreas Boland, Giorgio Ramadori, Roberto Coppari
S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Science advances 10 (1) (2024)
Christophe Kosinski, François R Jornayvaz, Karim Gariani
[The diabetic foot : a complex and multidisciplinary management]. Revue medicale suisse 19 (829) (2023)
Plator Memaj, Zayd Ouzerara, François R Jornayvaz
Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease. International journal of molecular sciences 24 (14) (2023)
Jorge César Correia, Ahmed Waqas, Soo Huat Teoh, Karim Gariani, François R Jornayvaz, Alain Golay, Zoltan Pataky
Effectiveness of Therapeutic Patient Education Interventions in Obesity and Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 14 (18) (2022)
Lorenzo A Orci, François R Jornayvaz, Christian Toso, Karim Gariani
Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease. Biomedicines 10 (9) (2022)
Alberto Nascè, Karim Gariani, François R Jornayvaz, Ildiko Szanto
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants (Basel, Switzerland) 11 (6) (2022)
Gloria Ursino, Giorgio Ramadori, Anna Höfler, Soline Odouard, Pryscila D S Teixeira, Florian Visentin, Christelle Veyrat-Durebex, Giulia Lucibello, Raquel Firnkes, Serena Ricci, Claudia R Vianna, Lin Jia, Mirjam Dirlewanger, Philippe Klee, Joel K Elmquist, Johannes Roth, Thomas Vogl, Valerie M Schwitzgebel, François R Jornayvaz, Andreas Boland, Roberto Coppari
Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis. Nature communications 13 (1) (2022)
Karim Gariani, François R Jornayvaz
NAFLD: From Mechanisms to Therapeutic Approaches. Biomedicines 10 (7) (2022)
Mohamed Asrih, Flore Sinturel, Richard Dubos, Idris Guessous, Zoltan Pataky, Charna Dibner, François R Jornayvaz, Karim Gariani
Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity. Endocrine connections 11 (7) (2022)
Maria Mavromati, François R Jornayvaz
Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD. International journal of molecular sciences 22 (23) (2021)
J Thomas Hannich, Ursula Loizides-Mangold, Flore Sinturel, Takeshi Harayama, Bart Vandereycken, Camille Saini, Pauline Gosselin, Marie-Claude Brulhart-Meynet, Maud Robert, Stephanie Chanon, Christine Durand, Jonathan Paz Montoya, Fabrice P A David, Idris Guessous, Zoltan Pataky, Alain Golay, François R Jornayvaz, Jacques Philippe, Emmanouil T Dermitzakis, Steven A Brown, Etienne Lefai, Howard Riezman, Charna Dibner
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. Acta physiologica (Oxford, England) 232 (1) (2021)
Robert Thomann, Stefan Zechmann, Nicola Alexander-David, François R Jornayvaz
Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Nicolas Goossens, François R Jornayvaz
Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease. Nutrients 9 (10) (2017)